Bleomycin sulfate from Streptomyces verticillus
SIGMA/B8416 - 1.5-2.0 units/mg solid, BioReagent, suitable for cell culture
Synonym: Blenoxane; Bleo; Blexane
CAS Number: 9041-93-4
EC Number: 232-925-2
MDL Number: MFCD00070310
Product Type: Chemical
| antibiotic activity spectrum | fungi |
| color | white to off-white |
| form | powder or crystals |
| InChI | 1S/2C55H83N17O21S3.H2O4S/ |
| InChI key | OOXTWFJZZAJGKA-CNLAFNBISA |
| mode of action | DNA synthesis | interferes |
| product line | BioReagent |
| Quality Level | 200 ![]() |
| SMILES string | [O-]S([O-])(=O)=O.C[C@@H] |
| solubility | H2O: 20 mg/mL, clear, colorless |
| specific activity | 1.5-2.0 units/mg solid |
| storage temp. | 2-8°C |
| technique(s) | cell culture | mammalian: suitable |
| Application: | Bleomycin is used in combination with Etoposide and Cisplatin to treat testicular, ovarian and cervical cancer. This combination is popular as BEP chemotherapy and has also been demonstrated as effective and most successful chemotherapy regimen in germ-cell tumors. Since it is a cytotoxic agent, bleomycin is known to induce endothelial damage the lung vasculature referred to as bleomycin-induced lung-injury or bleomycin-induced pneumonitis (BIP). Researchers have used this property of bleomycin to induce lung fibrosis in mouse and rat models. |
| Biochem/physiol Actions: | Bleomycin sulfate binds to DNA, causes ssDNA scission at specific base sequences and inhibits DNA synthesis. This inhibitory action requires bleomycin to bind oxygen and a metal ion. It can also cleave RNA, to a lesser degree but more selectively. It acts as an inducer and regulator of apoptosis and inhibits tumor angiogenesis. |
| Disclaimer: | This product should be stored at 2-8°C. |
| General description: | Bleomycin Sulfate is an antineoplastic antibiotic isolated from Streptomyces verticillus. It is recommended for use as a cell culture agent at 10-100 μg/mL. |
| General description: | Chemical structure: glycopeptide |
| Other Notes: | Keep container tightly closed in a dry and well-ventilated place, strongly hygroscopic |
| Other Notes: | This product is a mixture of glycopeptides antibiotics containing Bleomycin A2 (70%) and B2(30%). Bleomycins differ from each other in the terminal amine and show varying biological activity. |
| Packaging: | 15 units in serum bottle |
| Preparation Note: | The product is soluble in water in water at 20 mg/mL and is active for several days. A solution of 2 units/mL in 0.1 M neutral potassium phosphate should be used within 14 days. A solution is active for three months at 3 units/mL in normal saline. |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302 + H312 + H332 - H315 - H317 - H319 - H334 - H335 - H351 |
| Precautionary statements | P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 46-63-40 |
| Safety Statements | 36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| activity | specific activity: 1.5-2.0 units/mg solid |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352207 |



